Global Viral Inactivation Market, By Method (Solvent Detergent Method, Pasteurization and Other Viral Inactivation Method), Product (Kits and Reagents, Services, Viral Inactivation Systems and Accessories), Application (Blood and Blood Products, Cellular and Gene Therapy Products, Stem Cell Products, Tissue and Tissue Products, Vaccines and Therapeutics), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospitals, Academic Research Institutes and Other End Users), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Data Bridge Market Research analyses that the viral inactivation market will exhibit a CAGR of around 12.44% for the forecast period of 2021-2028. Rising support by the government to pharmaceutical and biotechnology companies, increased focus on research and development proficiencies and on the adoption of advanced healthcare technologies and rising expenditure on the healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of viral inactivation market.
Viral inactivation is a viral removal process wherein the viruses may remain in the final product but in a non-effective form. Viral inactivation is a crucial part of viral clearing process and is used for all kinds of pharmaceutical drugs.
Upsurge in the prevalence of chronic diseases globally is one of the major factors fostering the growth of the market. Rising focus on the healthcare technological advancements coupled with growth and expansion of pharmaceutical industries is another market growth determinant. Rising research and development proficiencies by life sciences industry, surge in the investments in Nano filtration technology, increasing commercialization of novel drugs and presence of major pipeline drugs will further generate lucrative market growth opportunities.
However, high costs associated with manufacturing bio similar products will act as a market growth restraint. Dearth of medical expertise in the under developed regions will further derail the market growth rate. Unfavourable reimbursement scenario in the developing and underdeveloped economies coupled with stringent regulatory scenario will further pose challenges for the market.
This viral inactivation market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on viral inactivation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Viral Inactivation Market Scope and Market Size
The viral inactivation market is segmented on the basis of method, product, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- The global viral inactivation market is segmented on the basis of method into solvent detergent method, pasteurization and other viral inactivation method.
- On the basis of product, the viral inactivation market is segmented into kits and reagents, services, viral inactivation systems and accessories.
- On the basis of application, the viral inactivation market is segmented into blood and blood products, cellular and gene therapy products, stem cell products, tissue and tissue products, vaccines and therapeutics.
- The global viral inactivation market is segmented on the basis of end user into pharmaceutical and biotechnology companies, contract research organizations, blood banks, hospital, academic research institutes and other end users.
Viral Inactivation Market Country Level Analysis
The viral inactivation market is analysed and market size insights and trends are provided by country, method, product, application and end user as referenced above.
The countries covered in the viral inactivation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the viral inactivation market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the prevailing advanced healthcare technologies and rising research and development proficiencies. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the growing prevalence of chronic diseases and increased expenditure for the development of healthcare infrastructure.
The country section of the viral inactivation market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The viral inactivation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the viral inactivation market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Viral Inactivation Market Share Analysis
The viral inactivation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to viral inactivation market.
The major players covered in the viral inactivation market report are Merck & Co., Inc., PARKER HANNIFIN CORP, Sartorius AG, Texcell, Cytiva, Danaher., SGS SA, Charles River Laboratories., Cleancells, Rad Source Technologies, WuXi AppTec, GENERAL ELECTRIC COMPANY, Sigma-Aldrich Co., Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation., TERUMO BCT, INC., Weigao group, SCI Automation., Pall Corporation and Eurofins Scientific among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.